InsidersTradesSigma
Explore the full record of transactions filed by Reed Joshua, Chief Financial Officer. Insider active across 1 companies, notably Aldeyra Therapeutics, Inc.. In total, 1 disclosures have been published. The latest transaction was disclosed on 30 March 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
1 of 1 declaration
Joshua Reed is the Chief Financial Officer of Aldeyra Therapeutics, Inc. He is responsible for the company's financial management, including budgeting and financial reporting. His expertise is essential for ensuring the financial health of the organization.